Resisting Targeted Therapy: Fifty Ways to Leave Your EGFR

Cancer Cell - Tập 19 - Trang 437-440 - 2011
Paul Workman1, Paul A. Clarke1
1Signal Transduction and Molecular Pharmacology Team, Cancer Research UK Cancer Therapeutics Unit, Division of Cancer Therapeutics, The Institute of Cancer Research, Haddow Laboratories, 15 Cotswold Road, Sutton SM2 5NG, UK

Tài liệu tham khảo

Bivona, 2011, Nature, 471, 523, 10.1038/nature09870 Druker, 2006, N. Engl. J. Med., 355, 2408, 10.1056/NEJMoa062867 Haber, 2005, Cold Spring Harb. Symp. Quant. Biol., 70, 419, 10.1101/sqb.2005.70.043 Jackman, 2010, J. Clin. Oncol., 28, 357, 10.1200/JCO.2009.24.7049 Mok, 2009, N. Eng. J. Med., 361, 947, 10.1056/NEJMoa0810699 Rosell, 2009, N. Eng. J. Med., 361, 958, 10.1056/NEJMoa0904554 Sawyers, 2009, Nat. Med., 15, 1158, 10.1038/nm1009-1158 Sequist, 2011, Sci. Transl. Med., 3, 75, 10.1126/scitranslmed.3002003 Weinstein, 2002, Science, 297, 63, 10.1126/science.1073096 Workman, 2010, Chem. Biol., 17, 561, 10.1016/j.chembiol.2010.05.013